|
|
||||||||
J Thorac Cardiovasc Surg 2006;131:1007-1013
© 2006 The American Association for Thoracic Surgery
General Thoracic Surgery |
a Division of General Thoracic Surgery, School of Medicine, Keio University, Tokyo, Japan
b Division of Diagnostic Radiology, School of Medicine, Keio University, Tokyo, Japan
Received for publication October 8, 2005; revisions received December 8, 2005; accepted for publication December 22, 2005. * Address for reprints: Masafumi Kawamura, MD, Division of General Thoracic Surgery, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan (Email: kawamura{at}sc.itc.keio.ac.jp).
OBJECTIVE: Cryoablation of pulmonary metastases might be a useful therapy for nonsurgical candidates.
METHODS: The procedure was performed after achievement of local anesthesia for 35 tumors in 20 patients (12 male and 8 female patients; mean age, 57 years). The primary end point was the safety and feasibility of cryoablation, and the secondary end point was tumor control assessed by follow-up dynamic computed tomographic scanning performed every 3 months.
RESULTS: Of the 22 sessions of cryoablation, pneumothorax occurred in 11, hemoptysis occurred in 8, and there was 1 case of phrenic nerve palsy. The mean hospital stay was 2.6 days. There was local recurrence of 7 (20%) tumors in 7 (35%) patients during a 9- to 28-month (median, 21 months) follow-up period. One-year survival according to the Kaplan-Meier method was 89.4%.
CONCLUSION: Percutaneous cryoablation therapy for metastatic lung tumors is feasible and minimally invasive, with satisfactory local control.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |